General MedicationsINTRAVENOUSGeneric

PROTAMINE SULFATE

Standard Dose

250MG/25ML (10MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview PROTAMINE SULFATE is listed in Drugs@FDA under application 089475 (ANDA).

Marketing status: Discontinued Active ingredient PROTAMINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 250MG/25ML (10MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2000-03-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROTAMINE SULFATE is listed in Drugs@FDA under application 089475 (ANDA). Marketing status: Discontinued Active ingredient PROTAMINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 250MG/25ML (10MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2000-03-29 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.